跳至主要内容
临床试验/NCT04563429
NCT04563429Unknown不适用

Vitamin A Oral Supplementation as a Preventive Treatment for Chronic Lung Disease Among Infants Born Before 29 Weeks of Gestation.

Sheba Medical Center0 个研究点目标入组 100 人开始时间: 2020年10月1日最近更新:
适应症

试验速览

阶段
不适用
入组人数
100
主要终点
Incidence of BPD at 28 days

研究概览

简要总结

Chronic bronchopulmonary dysplasia (BPD) is a very common complication in preterm infants born at a young gestational age, and is a serious disease that impairs respiratory long-term outcome and is associated with higher-frequency neurodevelopmental injury. Lowering the incidence of BPD may improve the health of the preterm babies and neurodevelopmental delay of preterm infants.Vitamin A deficiency may be one of the factors associated with the development of BPD in preterm infants. According to the literature, oral vitamin A administration can lower the incidence of BPD. In our study we plan to give 5000 units of retinol / dose / day, every day for 28 days.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
Triple (Participant, Care Provider, Investigator)

入排标准

年龄范围
2 Days 至 5 Days(Child)
性别
All
接受健康志愿者

入选标准

  • Premature babies under 29 weeks, at any birth weight
  • A preterm baby is less than 4 days to life

排除标准

  • Major congenital malformations
  • Known chromosomal disorders

结局指标

主要结局

Incidence of BPD at 28 days

时间窗: 28 days of life

Chronic pulmonary desease of prematue babies

Incidence of mortality at 28 days

时间窗: 28 days of life

Death before 28 days of life

次要结局

未报告次要终点

研究者

申办方类型
Other Gov
责任方
Principal Investigator
主要研究者

Dr. Leah Leibovitch MD

MD

Sheba Medical Center

相似试验